Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Sensing of oxygen in microtiter plates: a novel tool for screening drugs against pathogenic yeasts.

Wesolowski J, Hassan RY, Hodde S, Bardroff C, Bilitewski U.

Anal Bioanal Chem. 2008 Jul;391(5):1731-7. doi: 10.1007/s00216-008-1947-6. Epub 2008 Feb 24.

PMID:
18297273
2.

Integrated optical sensing of dissolved oxygen in microtiter plates: a novel tool for microbial cultivation.

John GT, Klimant I, Wittmann C, Heinzle E.

Biotechnol Bioeng. 2003 Mar 30;81(7):829-36.

PMID:
12557316
3.

Antifungal compounds redirect metabolic pathways in yeasts: metabolites as indicators of modes of action.

Wesolowski J, Hassan RY, Reinhardt K, Hodde S, Bilitewski U.

J Appl Microbiol. 2010 Feb;108(2):462-71. doi: 10.1111/j.1365-2672.2009.04443.x. Epub 2009 Jun 25.

4.

Myxothiazol, a new antibiotic interfering with respiration.

Thierbach G, Reichenbach H.

Antimicrob Agents Chemother. 1981 Apr;19(4):504-7.

5.

Kinetics of growth and sugar consumption in yeasts.

van Dijken JP, Weusthuis RA, Pronk JT.

Antonie Van Leeuwenhoek. 1993;63(3-4):343-52. Review.

PMID:
8279829
6.

Sodium azide reduces the thermotolerance of respiratively grown yeasts.

Rikhvanov EG, Varakina NN, Rusaleva TM, Rachenko EI, Voinikov VK.

Curr Microbiol. 2002 Dec;45(6):394-9.

PMID:
12402078
7.

Candida albicans--a pre-whole genome duplication yeast--is predominantly aerobic and a poor ethanol producer.

Rozpędowska E, Galafassi S, Johansson L, Hagman A, Piškur J, Compagno C.

FEMS Yeast Res. 2011 May;11(3):285-91. doi: 10.1111/j.1567-1364.2010.00715.x. Epub 2011 Feb 2.

8.
9.

Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.

Patterson TF, Revankar SG, Kirkpatrick WR, Dib O, Fothergill AW, Redding SW, Sutton DA, Rinaldi MG.

J Clin Microbiol. 1996 Jul;34(7):1794-7.

10.

Biological assay of fungicides against yeasts in vitro using a coulter counter.

Brotherton J.

Mykosen. 1976 Oct;19(10):361-72. No abstract available.

PMID:
794710
11.

Sensitivity of yeasts to 5-fluorocytosine.

Speller DC, Davies MG.

J Med Microbiol. 1973 Aug;6(3):315-21. No abstract available.

PMID:
4580062
12.
13.

In vitro effect of DNA topoisomerase inhibitors on Candida albicans.

Kwok SC, Schelenz S, Wang X, Steverding D.

Med Mycol. 2010 Feb;48(1):155-60. doi: 10.3109/13693780903114934.

PMID:
19626543
14.

Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts.

Fromtling RA, Galgiani JN, Pfaller MA, Espinel-Ingroff A, Bartizal KF, Bartlett MS, Body BA, Frey C, Hall G, Roberts GD, et al.

Antimicrob Agents Chemother. 1993 Jan;37(1):39-45.

15.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
16.

In vitro antifungal activity of Polyporaceae against yeasts and dermatophytes.

Steinmetz MD, Rascol JP, Régli P, Gargadennec A, Andary C.

Mycoses. 1995 Jul-Aug;38(7-8):305-9.

PMID:
8559195
17.

FTIR analysis of the metabolomic stress response induced by N-alkyltropinium bromide surfactants in the yeasts Saccharomyces cerevisiae and Candida albicans.

Corte L, Tiecco M, Roscini L, Germani R, Cardinali G.

Colloids Surf B Biointerfaces. 2014 Apr 1;116:761-71. doi: 10.1016/j.colsurfb.2014.01.054. Epub 2014 Feb 7.

PMID:
24582147
19.

Fermentative lifestyle in yeasts belonging to the Saccharomyces complex.

Merico A, Sulo P, Piskur J, Compagno C.

FEBS J. 2007 Feb;274(4):976-89. Epub 2007 Jan 18.

20.

A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.

Hamilton-Miller JM.

Sabouraudia. 1972 Nov;10(3):276-83. No abstract available.

PMID:
4565443

Supplemental Content

Support Center